GSI S/V (Epclusa sofosbuvir 200 mg / velpatasvir 50 mg)
Generic Name: sofosbuvir/velpatasvir
Pill with imprint GSI S/V is Pink, Elliptical / Oval and has been identified as Epclusa sofosbuvir 200 mg / velpatasvir 50 mg. It is supplied by Gilead Sciences, Inc..
Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 200 mg / velpatasvir 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI S/V
Epclusa
- Generic Name
- sofosbuvir/velpatasvir
- Imprint
- GSI S/V
- Strength
- sofosbuvir 200 mg / velpatasvir 50 mg
- Color
- Pink
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-2203
Related Images for "GSI S/V"
More about Epclusa (sofosbuvir / velpatasvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 298 Reviews
- Drug class: antiviral combinations
- FDA Approval History
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.